FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Katsuhito Mori

Research Profile

Disorders

Chemicals & Drugs

Procedures

Renal Dialysis

Concepts & Ideas

Devices

Glucose Clamp Technique

Anatomy

Co-author Network

Publications

TOP 3
Katsuhito Mori; Senji Okuno; Shigeichi Shoji; Tetsuo Shoji; Kenjiro Yamakawa; Tomoyuki Yamakawa; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Yoshinori Kakutani; Masaaki Inaba
Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents.
Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Naoya Kawano; Eiko Lee; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Masaaki Inaba
Clinical impact of the leptin to soluble leptin receptor ratio on subclinical carotid atherosclerosis in patients with type 2 diabetes.
Koichiro Yoda; Maki Yoda; Takashi Mishima; Katsuhito Mori; Shinsuke Yamada; Masanori Emoto; Mitsuru Ichii; Yasuo Imanishi; Masaaki Inaba
Impaired response of FGF-23 to oral phosphate in patients with type 2 diabetes: a possible mechanism of atherosclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Katsuhito Mori (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katsuhito Mori; Senji Okuno; Shigeichi Shoji; Tetsuo Shoji; Kenjiro Yamakawa; Tomoyuki Yamakawa; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Yoshinori Kakutani; Masaaki Inaba
Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents.
Cytokine 2013;61(3):912-6.
2013: Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Naoya Kawano; Eiko Lee; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Masaaki Inaba
Clinical impact of the leptin to soluble leptin receptor ratio on subclinical carotid atherosclerosis in patients with type 2 diabetes.
Journal of atherosclerosis and thrombosis 2013;20(2):186-94.
2012: Koichiro Yoda; Maki Yoda; Takashi Mishima; Katsuhito Mori; Shinsuke Yamada; Masanori Emoto; Mitsuru Ichii; Yasuo Imanishi; Masaaki Inaba
Impaired response of FGF-23 to oral phosphate in patients with type 2 diabetes: a possible mechanism of atherosclerosis.
The Journal of clinical endocrinology and metabolism 2012;97(11):E2036-43.
2012: Tetsuo Shoji; Tatsuji Takahashi; Masanori Emoto; Shinya Fukumoto; Akihide Matsumoto; Katsuhito Mori; Tomoaki Morioka; Yoshiki Nishizawa; Masaaki Inaba
Thrice-weekly insulin injection with nurse's support for diabetic hemodialysis patients having difficulty with self injection.
Osaka city medical journal 2012;58(1):35-8.
2012: Maki Yoda; Yasuo Imanishi; Masaaki Inaba; Eiji Ishimura; Katsuhito Mori; Senji Okuno; Tetsuo Shoji; Shinsuke Yamada; Tomoyuki Yamakawa; Koichiro Yoda; Shigeichi Shoji
Poor muscle quality as a predictor of high mortality independent of diabetes in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2012;66(4):266-70.
2012: Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Tetsuo Shoji; Shinsuke Yamada; Masanori Emoto; Yasuo Imanishi; Eiko Lee; Masaaki Inaba
Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus.
Diabetology & metabolic syndrome 2012;4(1):53.
2012: Katsuhito Mori; Masanori Emoto; Masaaki Inaba
Fetuin-A and the cardiovascular system.
Advances in clinical chemistry 2012;56():175-95.
2012: Naoya Kawano; Hidenori Koyama; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Yasuhisa Okuno; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Masaaki Inaba
Association of endothelial and vascular smooth muscle dysfunction with cardiovascular risk factors, vascular complications, and subclinical carotid atherosclerosis in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2012;19(3):276-84.
2012: Yasuo Imanishi; Wataru Ando; Jun Hashimoto; Hiroshi Kaji; Keisuke Kobayashi; Yasato Komatsu; Hajime M Koyano; Takami Miki; Akimitsu Miyauchi; Katsuhito Mori; Tomoaki Morioka; Yuki Nagata; Koichi Oba; Takatoshi Saito; Takafumi Ueda; Masaaki Inaba
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
Journal of bone and mineral metabolism 2012;30(1):93-9.
2011: Akinobu Ochi; Tetsuo Shoji; Tsutomu Tabata; Yoshihiro Tsujimoto; Hiroshi Yasuda; Eiji Ishimura; Ryusuke Kakiya; Katsuhito Mori; Yoshiki Nishizawa; Masaaki Inaba
Trace elements in the hair of hemodialysis patients.
Biological trace element research 2011;143(2):825-34.
2011: Yuki Nagata; Hiroshi Naka; Masanori Emoto; Yasuo Imanishi; Akira Ishii; Masafumi Kurajoh; Takami Miki; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Masaaki Inaba
Evaluation of bone markers in hypophosphatemic rickets/osteomalacia.
Endocrine 2011;40(2):315-7.
2011: Mizuki Aimoto; Mika Akahori-Nakamae; Mitsuru Ichii; Masaaki Inaba; Eiji Ishimura; Hideo Koh; Ki-Ryang Koh; Katsuhito Mori; Ran Moriguchi-Aimoto; Hirohisa Nakamae; Takahiko Nakane; Takafumi Nakao; Saori Nishiki-Kosaka; Masahiko Ohsawa; Yasunobu Takeoka; Yoshiki Terada; Eri Wada-Inoue; Kenichi Wakasa; Takahisa Yamane; Masayuki Hino
[Membranous nephropathy with nephrotic syndrome developed after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia].
[Rinshō ketsueki] The Japanese journal of clinical hematology 2011;52(7):556-62.
2011: Katsuhito Mori; Masanori Emoto; Masaaki Inaba
Fetuin-A: a multifunctional protein.
Recent patents on endocrine, metabolic & immune drug discovery 2011;5(2):124-46.
2011: Naoya Kawano; Katsuhito Mori; Masanori Emoto; Eiko Lee; Ikue Kobayashi; Yuko Yamazaki; Hiromi Urata; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Yoshiki Nishizawa; Masaaki Inaba
Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus.
Diabetes research and clinical practice 2011;91(3):316-20.
2011: Shinya Nakatani; Min Wei; Shotaro Yamano; Masaaki Inaba; Eiji Ishimura; Anna Kakehashi; Katsuhito Mori; Hideki Wanibuchi
Targeted proteomics of isolated glomeruli from the kidneys of diabetic rats: sorbin and SH3 domain containing 2 is a novel protein associated with diabetic nephropathy.
Experimental diabetes research 2011;2011():979354.
2010: Masaaki Inaba; M Kurajoh; Senji Okuno; Yasuo Imanishi; Shinsuke Yamada; Katsuhito Mori; Eiji Ishimura; Tomoyuki Yamakawa; Yoshiki Nishizawa
Poor muscle quality rather than reduced lean body mass is responsible for the lower serum creatinine level in hemodialysis patients with diabetes mellitus.
Clinical nephrology 2010;74(4):266-72.
2010: Hiroki Ueno; Hidenori Koyama; Takuhito Shoji; Masayo Monden; Shinya Fukumoto; Shinji Tanaka; Yoshiko Otsuka; Yohei Mima; Tomoaki Morioka; Katsuhito Mori; Atsushi Shioi; Hiroshi Yamamoto; Masaaki Inaba; Yoshiki Nishizawa
Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse.
Atherosclerosis 2010;211(2):431-6.
2010: Shuichi Jono; S Otsuki; Y Higashikuni; Atsushi Shioi; Katsuhito Mori; K Hara; H Hashimoto; Yuji Ikari
Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease.
Journal of thrombosis and haemostasis : JTH 2010;8(6):1170-5.
2010: Masanori Emoto; Katsuhito Mori; Eiko Lee; Naoya Kawano; Yuko Yamazaki; Shoko Tsuchikura; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2010;59(6):873-8.
2010: Hideaki Shima; Eiji Ishimura; Toshihide Naganuma; Takeshi Yamazaki; Ikue Kobayashi; Kaori Shidara; Katsuhito Mori; Yoshiaki Takemoto; Tetsuo Shoji; Masaaki Inaba; Mikio Okamura; Tatsuya Nakatani; Yoshiki Nishizawa
Cerebral microbleeds in predialysis patients with chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(5):1554-9.
2010: Katsuhito Mori; Yuji Ikari; Shuichi Jono; Atsushi Shioi; Eiji Ishimura; Masanori Emoto; Masaaki Inaba; Kazuhiro Hara; Yoshiki Nishizawa
Association of serum TRAIL level with coronary artery disease.
Thrombosis research 2010;125(4):322-5.
2010: Shinsuke Yamada; Masaaki Inaba; Shigeki Okada; Yasuo Imanishi; Katsuhito Mori; Masanori Emoto; Eiji Ishimura; Yoshiki Nishizawa
Association of glycated albumin, but not glycated hemoglobin, with calcaneus quantitative ultrasound in male hemodialysis patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2010;59(3):390-4.
2010: Katsuhito Mori; Shuichi Jono; Masanori Emoto; Takahiko Kawagishi; Hideo Yasumoto; Toshiaki Konishi; Yutaka Furumitsu; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes.
Angiology 2010;61(1):86-91.
2009: Eiko Lee; Masanori Emoto; Megumi Teramura; Shoko Tsuchikura; Hiroki Ueno; Kayo Shinohara; Tomoaki Morioka; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Yasuhisa Okuno; Masaaki Inaba; Yoshiki Nishizawa
The combination of IMT and stiffness parameter beta is highly associated with concurrent coronary artery disease in type 2 diabetes.
Journal of atherosclerosis and thrombosis 2009;16(1):33-9.
2009: Takahiro Araki; Masanori Emoto; Toshiaki Konishi; Yoshiko Ikuno; Eiko Lee; Megumi Teramura; Koka Motoyama; Hisayo Yokoyama; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Yoshiki Nishizawa
Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus.
Metabolism: clinical and experimental 2009;58(2):143-8.
2008: Katsuhito Mori; Masanori Emoto; Takahiro Araki; Hisayo Yokoyama; Eiko Lee; Megumi Teramura; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2008;57(9):1248-52.
2008: Hisayo Yokoyama; Katsuhito Mori; Masanori Emoto; Takahiro Araki; Megumi Teramura; K Mochizuki; T Tashiro; K Motozuka; Y Inoue; Yoshiki Nishizawa
Non-oxidative glucose disposal is reduced in type 2 diabetes, but can be restored by aerobic exercise.
Diabetes, obesity & metabolism 2008;10(5):400-7.
2007: Megumi Teramura; Masanori Emoto; Takahiro Araki; Hisayo Yokoyama; Koka Motoyama; Kayo Shinohara; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Clinical impact of metabolic syndrome by modified NCEP-ATPIII criteria on carotid atherosclerosis in Japanese adults.
Journal of atherosclerosis and thrombosis 2007;14(4):172-8.
2007: Katsuhito Mori; Shuichi Jono
[Calcified coronary artery disease and serum markers].
Clinical calcium 2007;17(3):340-5.
2007: Katsuhito Mori; Masanori Emoto; Takahiro Araki; Hisayo Yokoyama; Megumi Teramura; Eiko Lee; Koka Motoyama; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Association of serum fetuin-A with carotid arterial stiffness.
Clinical endocrinology 2007;66(2):246-50.
2007: Sawako Hatsuda; Tetsuo Shoji; Kayo Shinohara; Eiji Kimoto; Katsuhito Mori; Shinya Fukumoto; Hidenori Koyama; Masanori Emoto; Yoshiki Nishizawa
Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects.
Journal of vascular research 2007;44(1):61-6.
2007: Hidenori Koyama; Tetsuo Shoji; Shinya Fukumoto; Kayo Shinohara; Tetsuo Shoji; Masanori Emoto; Katsuhito Mori; Hideki Tahara; Eiji Ishimura; Ryusuke Kakiya; Tsutomu Tabata; Hiroshi Yamamoto; Yoshiki Nishizawa
Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(1):147-53.
2006: Katsuhito Mori; Masanori Emoto
[Stroke and diabetes mellitus].
Nihon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 7():677-80.
2006: Tetsuo Shoji; Hidenori Koyama; Tomoaki Morioka; Shinji Tanaka; Akane Kizu; Kohka Motoyama; Katsuhito Mori; Shinya Fukumoto; Atsushi Shioi; Noriko Shimogaito; Masayoshi Takeuchi; Yasuhiko Yamamoto; Hideto Yonekura; Hiroshi Yamamoto; Yoshiki Nishizawa
Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Diabetes 2006;55(8):2245-55.
2006: Takahiro Araki; Masanori Emoto; Megumi Teramura; Hisayo Yokoyama; Katsuhito Mori; Sawako Hatsuda; Takaaki Maeno; Kayo Shinohara; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin.
Metabolism: clinical and experimental 2006;55(8):996-1001.
2006: Eiji Kimoto; Tetsuo Shoji; Kayo Shinohara; Sawako Hatsuda; Katsuhito Mori; Shinya Fukumoto; Hidenori Koyama; Masanori Emoto; Yasuhisa Okuno; Yoshiki Nishizawa
Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease.
Journal of the American Society of Nephrology : JASN 2006;17(8):2245-52.
2006: Takahiro Araki; Masanori Emoto; Hisayo Yokoyama; Takaaki Maeno; Sawako Hatsuda; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
The association of plasma adiponectin level with carotid arterial stiffness.
Metabolism: clinical and experimental 2006;55(5):587-92.
2006: Sawako Hatsuda; Tetsuo Shoji; Kayo Shinohara; Eiji Kimoto; Katsuhito Mori; Shinya Fukumoto; Hidenori Koyama; Masanori Emoto; Yoshiki Nishizawa
Regional arterial stiffness associated with ischemic heart disease in type 2 diabetes mellitus.
Journal of atherosclerosis and thrombosis 2006;13(2):114-21.
2006: Hisayo Yokoyama; Masanori Emoto; Katsuhito Mori; Takahiro Araki; Megumi Teramura; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.
The Journal of clinical endocrinology and metabolism 2006;91(1):290-4.
2005: Hidenori Koyama; Tetsuo Shoji; Hisayo Yokoyama; Kohka Motoyama; Katsuhito Mori; Shinya Fukumoto; Masanori Emoto; Tetsuo Shoji; Hironori Tamei; Hirokazu Matsuki; Shigeru Sakurai; Yasuhiko Yamamoto; Hideto Yonekura; Takuo Watanabe; Hiroshi Yamamoto; Yoshiki Nishizawa
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(12):2587-93.
2002: Shuichi Jono; Yuji Ikari; Atsushi Shioi; Katsuhito Mori; Takami Miki; Kazuhiro Hara; Yoshiki Nishizawa
Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease.
Circulation 2002;106(10):1192-4.
2002: Atsushi Shioi; Miwako Katagi; Yasuhisa Okuno; Katsuhito Mori; Shuichi Jono; Hidenori Koyama; Yoshiki Nishizawa
Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages.
Circulation research 2002;91(1):9-16.
2001: Masanori Emoto; H Kanda; Tetsuo Shoji; Takahiko Kawagishi; Miyoko Komatsu; Katsuhito Mori; Hideki Tahara; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; Yoshiki Nishizawa
Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes.
Diabetes care 2001;24(3):533-8.
1999: Katsuhito Mori; Atsushi Shioi; Shuichi Jono; Yoshiki Nishizawa; Hirotoshi Morii
Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(9):2112-8.
1997: Masanori Emoto; Yoshiki Nishizawa; Kiyoshi Maekawa; Takahiko Kawagishi; K Kogawa; Yoshikazu Hiura; Katsuhito Mori; S Tanaka; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; Hirotoshi Morii
Insulin resistance in non-obese, non-insulin-dependent diabetic patients with diabetic nephropathy.
Metabolism: clinical and experimental 1997;46(9):1013-8.